RENALYTIX PLC Logo

RENALYTIX PLC

Develops AI-enabled diagnostic solutions for the clinical management of kidney disease.

RENX | IL

Overview

Corporate Details

ISIN(s):
GB00BYWL4Y04 (+1 more)
LEI:
213800NTOH3FK3WER551
Country:
United Kingdom
Address:
2 LEMAN STREET, E1W 9US LONDON

Description

Renalytix is a diagnostics company that develops artificial intelligence-enabled solutions for the clinical management of kidney disease. Its flagship product, KidneyIntelX.dkd™, is an FDA-authorized blood test for adults with type 2 diabetes and early-stage chronic kidney disease. The test utilizes a proprietary bioprognostic™ methodology to analyze biomarkers and clinical data, predicting the risk of a progressive decline in kidney function over a five-year period. This risk assessment enables clinicians to identify high-risk patients and implement targeted, guideline-recommended treatments to slow disease progression and improve outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-09 12:10
Result of AGM
English 33.5 KB
2025-12-09 08:20
AGM Statement
English 20.0 KB
2025-11-27 15:50
Holding(s) in Company
English 49.8 KB
2025-11-25 16:55
Holding(s) in Company
English 50.2 KB
2025-11-25 08:25
Plan to Implement ADS Ratio Change
English 18.4 KB
2025-11-12 08:30
Pivotal kidneyintelX.dkd data published
English 27.0 KB
2025-11-05 17:15
Holding(s) in Company
English 49.8 KB
2025-11-04 19:15
Publication of Annual Report & Notice of AGM
English 16.4 KB
2025-11-03 13:20
Holding(s) in Company
English 49.8 KB
2025-11-03 08:25
Audited Full Year Fiscal 2025 Results
English 615.2 KB
2025-10-30 17:58
Holding(s) in Company
English 51.4 KB
2025-10-28 17:04
Holding(s) in Company
English 51.4 KB
2025-10-24 11:12
Holding(s) in Company
English 51.4 KB
2025-10-23 10:09
Holding(s) in Company
English 51.7 KB
2025-10-21 11:08
Holding(s) in Company
English 51.3 KB

Automate Your Workflow. Get a real-time feed of all RENALYTIX PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RENALYTIX PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for RENALYTIX PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

biote Corp. Logo
A practice-building business focused on bioidentical hormone replacement therapy.
United States of America
BTMD
BML, INC. Logo
Provider of laboratory testing services and medical information systems.
Japan
4694
BrightSpring Health Services, Inc. Logo
Provider of home and community-based health and pharmacy services for complex populations.
United States of America
BTSG
CareDx, Inc. Logo
Develops diagnostic solutions and genomics-based tests for organ transplant patients.
United States of America
CDNA
Caris Life Sciences, Inc. Logo
Biotechnology firm using molecular science and AI for precision cancer care.
United States of America
CAI
CASTLE BIOSCIENCES INC Logo
A diagnostics company developing molecular tests for dermatologic cancers.
United States of America
CSTL
CellSource Co.,Ltd. Logo
Provides cell and tissue processing services for regenerative medicine.
Japan
4880
CHEMED CORP Logo
Operates subsidiaries in hospice care and plumbing and drain cleaning services.
United States of America
CHE
Concentra Group Holdings Parent, Inc. Logo
Provider of occupational health services for the workforce via a national clinic network.
United States of America
CON
Constance Care Spolka Akcyjna W Restrukturyzacji Logo
Medical center for neurological rehabilitation using manual and robotic therapies.
Poland
CCR

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.